Your session is about to expire
← Back to Search
Early postpartum visit for Postpartum Depression
N/A
Waitlist Available
Led By Martha B Kole-White, MD
Research Sponsored by Women and Infants Hospital of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial assesses if an extra early postpartum visit improves attendance at postpartum visits, education, satisfaction, or trust in clinicians.
Eligible Conditions
- Postpartum Weight Retention
- Postpartum Depression
- Patient Satisfaction
- Trust
- Breastfeeding
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of postpartum visits attended
Secondary outcome measures
Number of emergency room visits
Number of recommended items covered during postpartum care
Short Assessment of Patient Satisfaction
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Early & Often Postpartum CareExperimental Treatment2 Interventions
Visit at 2-3 and 6 weeks postpartum.
Group II: Standard Postpartum CarePlacebo Group1 Intervention
Visit at 6 weeks postpartum.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Early postpartum visit
2021
N/A
~170
Standard postpartum visit
2021
N/A
~170
Find a Location
Who is running the clinical trial?
Women and Infants Hospital of Rhode IslandLead Sponsor
110 Previous Clinical Trials
38,654 Total Patients Enrolled
3 Trials studying Postpartum Depression
950 Patients Enrolled for Postpartum Depression
Martha B Kole-White, MDPrincipal InvestigatorWomen & Infants Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this a geriatric clinical trial?
"Based on the age parameters set out in the inclusion criteria, the eligible age range for this trial is 13 to 50 years old."
Answered by AI
Does this clinical trial have any restrictions on who can participate?
"The ideal candidate for this clinical trial should be trustworthy and between the ages of adolescence and early adulthood. Around 162 patients are needed for the study."
Answered by AI
Share this study with friends
Copy Link
Messenger